Draft guideline on good pharmacovigilance practices (GVP) - Product- or population-specific considerations IV: paediatric population

  • Email
  • Help

Document details

Download document Draft guideline on good pharmacovigilance practices (GVP) - Product- or population-specific considerations IV: paediatric population
Reference number EMA/572054/2016
Status draft: consultation closed
First published 2017-08-02
Last updated 2017-08-02

Summary

The paediatric population is defined in the European Union (EU) as that part of the population aged between birth and 18 years. The paediatric population encompasses several subsets.